Bayer: Pain trials
The registry lists 14 Pain studies with Bayer as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 8Phase 3 4Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Collect Information on How Well the Study Drug Naproxen Sodium Tablets Works Compared to Hydrocodone/Acetaminophen Tablets in Order to Relieve Pain in Participants Experiencing Moderate to Severe Pain After Having Their Wisdom Teeth RemovedCompletedNCT04307940Phase 4Results posted
- Actual Use Trial of Naproxen SodiumCompletedNCT01427803Phase 3Results posted
- Self Selection Trial of Naproxen SodiumCompletedNCT01383486Phase 3Results posted
- Safety Trial of Naproxen Sodium/ DiphenhydramineCompletedNCT01365052Phase 3Results posted
- Naproxen Sodium Extended-Release Actual Use StudyCompletedNCT00751400Phase 3Results posted
- A Study to Learn About Whether BAYH006689 Causes Skin Irritation When Applied as a Topical Gel in Healthy ParticipantsCompletedNCT06511973Phase 1
- A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy ParticipantsCompletedNCT06415019Phase 1
- Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult ParticipantsCompletedNCT04252300Phase 1
- A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult SubjectsCompletedNCT03396250Phase 1
- A Study to Assess Disintegration of the New Aspirin Disintegrating TabletsCompletedNCT03225352Phase 1
- Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin TabletsCompletedNCT03056703Phase 1
- A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and InstabilityCompletedNCT02682654Not applicable
- Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times DailyCompletedNCT02549469Phase 1
- Naproxen Sodium ER Pharmacokinetic StudyCompletedNCT00818415Phase 1